nodes	percent_of_prediction	percent_of_DWPC	metapath
Theobromine—ADORA2A—HIF-2-alpha transcription factor network—CITED2—bone cancer	0.113	0.114	CbGpPWpGaD
Theobromine—CYP2E1—Felbamate Metabolism—CYP3A4—bone cancer	0.0991	0.101	CbGpPWpGaD
Theobromine—CYP1A2—Lidocaine metabolism—CYP3A4—bone cancer	0.0596	0.0605	CbGpPWpGaD
Theobromine—CYP2E1—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.0325	0.0331	CbGpPWpGaD
Theobromine—ADORA1—Circadian rythm related genes—TNFRSF11A—bone cancer	0.0227	0.023	CbGpPWpGaD
Theobromine—CYP1A2—Aflatoxin B1 metabolism—CYP3A4—bone cancer	0.0219	0.0222	CbGpPWpGaD
Theobromine—CYP1A2—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.0196	0.0199	CbGpPWpGaD
Theobromine—CYP2E1—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.0188	0.0191	CbGpPWpGaD
Theobromine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.0176	0.0179	CbGpPWpGaD
Theobromine—ADORA2A—Circadian rythm related genes—TNFRSF11A—bone cancer	0.0175	0.0178	CbGpPWpGaD
Theobromine—ADORA2A—GPCRs, Other—GRM1—bone cancer	0.0173	0.0176	CbGpPWpGaD
Theobromine—PDE4B—Myometrial Relaxation and Contraction Pathways—RGS1—bone cancer	0.0167	0.017	CbGpPWpGaD
Theobromine—CYP2E1—Xenobiotics—CYP3A4—bone cancer	0.0157	0.016	CbGpPWpGaD
Theobromine—CYP2E1—Tamoxifen metabolism—CYP3A4—bone cancer	0.0151	0.0153	CbGpPWpGaD
Theobromine—PDE4B—G Protein Signaling Pathways—GNA11—bone cancer	0.014	0.0143	CbGpPWpGaD
Theobromine—CYP2E1—Metapathway biotransformation—CYP4V2—bone cancer	0.014	0.0142	CbGpPWpGaD
Theobromine—ADORA2A—GPCRs, Other—SMO—bone cancer	0.0122	0.0124	CbGpPWpGaD
Theobromine—ADORA1—G alpha (i) signalling events—GRM4—bone cancer	0.0121	0.0123	CbGpPWpGaD
Theobromine—ADORA1—G alpha (i) signalling events—RGS1—bone cancer	0.0121	0.0123	CbGpPWpGaD
Theobromine—CYP1A2—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.0113	0.0115	CbGpPWpGaD
Theobromine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.0106	0.0107	CbGpPWpGaD
Theobromine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.0103	0.0104	CbGpPWpGaD
Theobromine—CYP1A2—Estrogen metabolism—CYP3A4—bone cancer	0.0103	0.0104	CbGpPWpGaD
Theobromine—CYP1A2—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.00984	0.00999	CbGpPWpGaD
Theobromine—CYP1A2—Xenobiotics—CYP3A4—bone cancer	0.00944	0.00959	CbGpPWpGaD
Theobromine—CYP1A2—Tamoxifen metabolism—CYP3A4—bone cancer	0.00908	0.00923	CbGpPWpGaD
Theobromine—PDE4B—Myometrial Relaxation and Contraction Pathways—ATF1—bone cancer	0.00868	0.00882	CbGpPWpGaD
Theobromine—CYP1A2—Metapathway biotransformation—CYP4V2—bone cancer	0.00842	0.00856	CbGpPWpGaD
Theobromine—CYP2E1—Tryptophan metabolism—CYP3A4—bone cancer	0.00807	0.0082	CbGpPWpGaD
Theobromine—Theophylline—CYP3A4—bone cancer	0.00798	0.505	CrCbGaD
Theobromine—Caffeine—CYP3A4—bone cancer	0.00783	0.495	CrCbGaD
Theobromine—ADORA1—Circadian rythm related genes—GNA11—bone cancer	0.00767	0.0078	CbGpPWpGaD
Theobromine—ADORA1—Circadian rythm related genes—EZH2—bone cancer	0.00764	0.00776	CbGpPWpGaD
Theobromine—ADORA1—GPCR ligand binding—GRM4—bone cancer	0.00734	0.00745	CbGpPWpGaD
Theobromine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00652	0.00663	CbGpPWpGaD
Theobromine—CYP2E1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00644	0.00654	CbGpPWpGaD
Theobromine—ADORA1—GPCR ligand binding—GRM1—bone cancer	0.00636	0.00646	CbGpPWpGaD
Theobromine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00618	0.00627	CbGpPWpGaD
Theobromine—ADORA2A—Circadian rythm related genes—GNA11—bone cancer	0.00592	0.00602	CbGpPWpGaD
Theobromine—ADORA2A—Circadian rythm related genes—EZH2—bone cancer	0.0059	0.00599	CbGpPWpGaD
Theobromine—ADORA2A—GPCR ligand binding—GRM4—bone cancer	0.00566	0.00576	CbGpPWpGaD
Theobromine—ADORA2A—NGF signalling via TRKA from the plasma membrane—ATF1—bone cancer	0.0054	0.00549	CbGpPWpGaD
Theobromine—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	0.00532	0.00541	CbGpPWpGaD
Theobromine—CYP2E1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00529	0.00537	CbGpPWpGaD
Theobromine—ADORA2A—GPCR ligand binding—GRM1—bone cancer	0.00491	0.00499	CbGpPWpGaD
Theobromine—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	0.00485	0.00493	CbGpPWpGaD
Theobromine—ADORA1—GPCR ligand binding—SMO—bone cancer	0.00448	0.00455	CbGpPWpGaD
Theobromine—ADORA1—Circadian rythm related genes—CDK4—bone cancer	0.00431	0.00438	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by NGF—ATF1—bone cancer	0.00415	0.00422	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—RGS1—bone cancer	0.00415	0.00421	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—GRM4—bone cancer	0.00415	0.00421	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—GRM4—bone cancer	0.0041	0.00416	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—RGS1—bone cancer	0.0041	0.00416	CbGpPWpGaD
Theobromine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00392	0.00398	CbGpPWpGaD
Theobromine—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00387	0.00393	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—GRM4—bone cancer	0.00377	0.00383	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—RGS1—bone cancer	0.00377	0.00383	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—RGS1—bone cancer	0.00372	0.00378	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—GRM4—bone cancer	0.00372	0.00378	CbGpPWpGaD
Theobromine—CYP2E1—Tryptophan metabolism—MDM2—bone cancer	0.00371	0.00377	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—GRM1—bone cancer	0.00359	0.00365	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—GRM1—bone cancer	0.00355	0.00361	CbGpPWpGaD
Theobromine—ADORA2A—GPCR ligand binding—SMO—bone cancer	0.00346	0.00352	CbGpPWpGaD
Theobromine—PDE4B—Myometrial Relaxation and Contraction Pathways—JUN—bone cancer	0.00338	0.00343	CbGpPWpGaD
Theobromine—ADORA2A—Circadian rythm related genes—CDK4—bone cancer	0.00333	0.00338	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—GRM1—bone cancer	0.00326	0.00332	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—GRM1—bone cancer	0.00323	0.00328	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—GRM4—bone cancer	0.0032	0.00325	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—RGS1—bone cancer	0.0032	0.00325	CbGpPWpGaD
Theobromine—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00318	0.00323	CbGpPWpGaD
Theobromine—ADORA2A—NGF signalling via TRKA from the plasma membrane—KIT—bone cancer	0.00307	0.00312	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—GRM4—bone cancer	0.00291	0.00295	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—RGS1—bone cancer	0.00291	0.00295	CbGpPWpGaD
Theobromine—ADORA2A—NGF signalling via TRKA from the plasma membrane—BRAF—bone cancer	0.00289	0.00293	CbGpPWpGaD
Theobromine—CYP2E1—Biological oxidations—CYP3A4—bone cancer	0.00281	0.00285	CbGpPWpGaD
Theobromine—ADORA1—Circadian rythm related genes—JUN—bone cancer	0.00278	0.00282	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—GRM1—bone cancer	0.00278	0.00282	CbGpPWpGaD
Theobromine—CYP2E1—Metapathway biotransformation—CYP3A4—bone cancer	0.00277	0.00281	CbGpPWpGaD
Theobromine—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.00261	0.00266	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—GRM1—bone cancer	0.00252	0.00256	CbGpPWpGaD
Theobromine—CYP1A2—Phase II conjugation—GSTP1—bone cancer	0.00247	0.00251	CbGpPWpGaD
Theobromine—ADORA2A—NGF signalling via TRKA from the plasma membrane—MDM2—bone cancer	0.00242	0.00246	CbGpPWpGaD
Theobromine—CYP2E1—Biological oxidations—GSTP1—bone cancer	0.0024	0.00244	CbGpPWpGaD
Theobromine—CYP2E1—Metapathway biotransformation—GSTP1—bone cancer	0.00237	0.00241	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by NGF—KIT—bone cancer	0.00236	0.0024	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—GNA11—bone cancer	0.00232	0.00235	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—SMO—bone cancer	0.0023	0.00234	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—GNA11—bone cancer	0.00229	0.00233	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—SMO—bone cancer	0.00227	0.00231	CbGpPWpGaD
Theobromine—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	0.00223	0.00226	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—RGS1—bone cancer	0.00222	0.00226	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—GRM4—bone cancer	0.00222	0.00226	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by NGF—BRAF—bone cancer	0.00222	0.00226	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—RGS1—bone cancer	0.0022	0.00223	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—GRM4—bone cancer	0.0022	0.00223	CbGpPWpGaD
Theobromine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.00215	0.00218	CbGpPWpGaD
Theobromine—ADORA2A—Circadian rythm related genes—JUN—bone cancer	0.00215	0.00218	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—GNA11—bone cancer	0.0021	0.00214	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—IL3—bone cancer	0.0021	0.00213	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—GNA11—bone cancer	0.00208	0.00211	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—IL3—bone cancer	0.00208	0.00211	CbGpPWpGaD
Theobromine—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	0.00201	0.00204	CbGpPWpGaD
Theobromine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.00194	0.00197	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—GRM1—bone cancer	0.00193	0.00196	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—IL3—bone cancer	0.00191	0.00194	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—GRM1—bone cancer	0.00191	0.00194	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—IL3—bone cancer	0.00188	0.00191	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by NGF—MDM2—bone cancer	0.00186	0.00189	CbGpPWpGaD
Theobromine—ADORA1—Circadian rythm related genes—TP53—bone cancer	0.00183	0.00186	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—GNA11—bone cancer	0.00179	0.00182	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—SMO—bone cancer	0.00178	0.0018	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—GRM4—bone cancer	0.00172	0.00174	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—RGS1—bone cancer	0.00172	0.00174	CbGpPWpGaD
Theobromine—CYP1A2—Biological oxidations—CYP3A4—bone cancer	0.00169	0.00172	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—NDUFA12—bone cancer	0.00168	0.00171	CbGpPWpGaD
Theobromine—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	0.00167	0.00169	CbGpPWpGaD
Theobromine—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—bone cancer	0.00165	0.00168	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—GNA11—bone cancer	0.00162	0.00165	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—IL3—bone cancer	0.00162	0.00165	CbGpPWpGaD
Theobromine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.00152	0.00155	CbGpPWpGaD
Theobromine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	0.00152	0.00155	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—GRM1—bone cancer	0.00149	0.00151	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—IL3—bone cancer	0.00147	0.0015	CbGpPWpGaD
Theobromine—CYP1A2—Biological oxidations—GSTP1—bone cancer	0.00144	0.00147	CbGpPWpGaD
Theobromine—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	0.00142	0.00145	CbGpPWpGaD
Theobromine—ADORA2A—Circadian rythm related genes—TP53—bone cancer	0.00142	0.00144	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—NT5C3A—bone cancer	0.00139	0.00142	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—SMO—bone cancer	0.00136	0.00138	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—SMO—bone cancer	0.00134	0.00136	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by NGF—EGFR—bone cancer	0.00127	0.00129	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—GNA11—bone cancer	0.00124	0.00126	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—GNA11—bone cancer	0.00123	0.00125	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—ATF1—bone cancer	0.00116	0.00117	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—ATF1—bone cancer	0.00114	0.00116	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—IL3—bone cancer	0.00113	0.00114	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—IL3—bone cancer	0.00111	0.00113	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—SMO—bone cancer	0.00105	0.00107	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—NDUFA12—bone cancer	0.00101	0.00103	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—TGFBR2—bone cancer	0.000964	0.000979	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—GNA11—bone cancer	0.000959	0.000975	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—TGFBR2—bone cancer	0.000952	0.000967	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—IGF1R—bone cancer	0.000907	0.000921	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—IGF1R—bone cancer	0.000896	0.00091	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—ATF1—bone cancer	0.000892	0.000906	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—IL3—bone cancer	0.00087	0.000884	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—NT5C3A—bone cancer	0.000839	0.000852	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—TGFBR2—bone cancer	0.000744	0.000756	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—IGF1R—bone cancer	0.0007	0.000711	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—KIT—bone cancer	0.000657	0.000668	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—KIT—bone cancer	0.00065	0.00066	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—BRAF—bone cancer	0.000618	0.000628	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—ENO2—bone cancer	0.000611	0.000621	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—BRAF—bone cancer	0.000611	0.00062	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—EGFR—bone cancer	0.000599	0.000609	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—EGFR—bone cancer	0.000592	0.000601	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—DHFR—bone cancer	0.000567	0.000576	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—GNA11—bone cancer	0.00053	0.000538	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—MDM2—bone cancer	0.000518	0.000526	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—MDM2—bone cancer	0.000512	0.00052	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—KIT—bone cancer	0.000508	0.000516	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—CYP3A4—bone cancer	0.00048	0.000488	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—BRAF—bone cancer	0.000477	0.000485	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—EGFR—bone cancer	0.000462	0.00047	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—JUN—bone cancer	0.00045	0.000457	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—JUN—bone cancer	0.000445	0.000452	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—MMP9—bone cancer	0.000438	0.000445	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—MMP9—bone cancer	0.000433	0.00044	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—GSTP1—bone cancer	0.000411	0.000417	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—MDM2—bone cancer	0.0004	0.000406	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—ENO2—bone cancer	0.000367	0.000373	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—EGFR—bone cancer	0.000354	0.00036	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—EGFR—bone cancer	0.00035	0.000355	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—JUN—bone cancer	0.000348	0.000353	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—DHFR—bone cancer	0.000341	0.000346	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—MMP9—bone cancer	0.000338	0.000344	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—GNA11—bone cancer	0.000318	0.000324	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—TP53—bone cancer	0.000297	0.000302	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—TP53—bone cancer	0.000294	0.000298	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—CYP3A4—bone cancer	0.000289	0.000293	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000287	0.000292	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—EGFR—bone cancer	0.000273	0.000278	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—GSTP1—bone cancer	0.000247	0.000251	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—TP53—bone cancer	0.000229	0.000233	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—PTGS2—bone cancer	0.000213	0.000216	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—PTGS2—bone cancer	0.000128	0.00013	CbGpPWpGaD
